Tiagabine Keto Analog | CAS 161014-55-7 - Request Quote
Tiagabine Keto Analog
| SZ CAT No: | SZ-T055005 |
| CAS No | 161014-55-7 |
| Mol.F. | C20H25NO3S2 |
| Mol.Wt. | 391.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tiagabine Keto Analog is chemically (R)-1-[4,4-Bis(3-methylthiophen-2-yl)-3-oxobutyl]piperidine-3-carboxylic acid (as per USP). Tiagabine Keto Analog is supplied with detailed characterization data compliant with regulatory guideline. Tiagabine Keto Analog can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tiagabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 161014-55-7
Purchase 161014-55-7
Order 161014-55-7
Enquire 161014-55-7
price of 161014-55-7
161014-55-7 Supplier
161014-55-7 Manufacturer
161014-55-7 Exporter
buy high quality Tiagabine Keto Analog
Purchase Tiagabine Keto Analog
Tiagabine Keto Analog suppliers
Tiagabine Keto Analog manufacturers
Tiagabine Keto Analog price
Order Tiagabine Keto Analog
Enquire Tiagabine Keto Analog
Tiagabine Keto Analog cost
Tiagabine Keto Analog Supplier
Tiagabine Keto Analog Distributor
Tiagabine Keto Analog for Method Validation
Tiagabine Reference Standard
Tiagabine Keto Analog for ANDA Filing
Tiagabine Keto Analog for Forced Degradation Studies
Tiagabine Keto Analog Identification Standards
Tiagabine Keto Analog for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.